Cargando…
Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
There is a vast disagreement in relation to the possible beneficial effects of omega-3 polyunsaturated fatty acids (omega-3 PUFA) supplementation in patients with diabetes and cardiovascular disease. The conflicting results between the various original studies and meta-analyses could be partially ex...
Autores principales: | Tenenbaum, Alexander, Fisman, Enrique Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112138/ https://www.ncbi.nlm.nih.gov/pubmed/30153832 http://dx.doi.org/10.1186/s12933-018-0766-0 |
Ejemplares similares
-
Effects of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation on Cardiovascular Mortality: The Importance of the Dose of DHA
por: Meyer, Barbara J., et al.
Publicado: (2017) -
An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
por: Elagizi, Andrew, et al.
Publicado: (2021) -
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health
por: Rodriguez, Daniel, et al.
Publicado: (2022) -
An Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids
por: Yanai, Hidekatsu, et al.
Publicado: (2018) -
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015)